GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
320 hedge funds and large institutions have $3.94B invested in GW Pharmaceuticals Plc American Depositary Shares in 2019 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 76 increasing their positions, 91 reducing their positions, and 37 closing their positions.
127% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 37
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
73% more capital invested
Capital invested by funds: $2.28B → $3.94B (+$1.66B)
16% more funds holding
Funds holding: 277 → 320 (+43)
16% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 91
35% less call options, than puts
Call options by funds: $126M | Put options by funds: $195M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$177M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$44.3M |
| 3 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$28.9M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$27.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$20M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$88.6M |
| 2 |
Barclays
London,
United Kingdom
|
-$64.1M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42.2M |
| 4 |
FAM
Fred Alger Management
New York
|
-$42.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$41.9M |
GWPH Hedge Fund Activity: Q1 2019 in Review
320 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2019, worth a combined $3.94B — up 73% from $2.28B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new GWPH positions and 37 closed out — a net gain of 47 holders — while 76 added to existing stakes and 91 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $177M. The largest seller was Scopia Capital Management, cutting an estimated $88.6M.
- 320 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2019, up from 277 in Q4 2018.
- Funds reported $3.94B of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2019, up 73% quarter-over-quarter.
- 84 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2019 and 37 closed out, a net change of +47 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2019 was Franklin Resources, an estimated $177M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2019 was Scopia Capital Management, an estimated $88.6M sold.
Based on aggregated 13F filings for Q1 2019.